These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 7865176)
1. The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats. Dluzen DE; Liu B J Neural Transm Gen Sect; 1994; 95(3):209-22. PubMed ID: 7865176 [TBL] [Abstract][Full Text] [Related]
2. L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine. Dluzen DE; Kratko FT J Neural Transm Gen Sect; 1992; 89(3):197-207. PubMed ID: 1389004 [TBL] [Abstract][Full Text] [Related]
3. Alteration in L-DOPA evoked dopamine and DOPAC output under conditions of impaired vesicular dopamine storage. Xu K; Dluzen DE J Neural Transm (Vienna); 1998; 105(10-12):1091-101. PubMed ID: 9928880 [TBL] [Abstract][Full Text] [Related]
4. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [TBL] [Abstract][Full Text] [Related]
5. The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats. Dluzen DE; McDermott JL J Neural Transm Gen Sect; 1991; 85(2):145-56. PubMed ID: 1930877 [TBL] [Abstract][Full Text] [Related]
6. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Biggs CS; Starr MS Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170 [TBL] [Abstract][Full Text] [Related]
7. Striatal dopamine release in vitro from immature male rats shows enhanced responsiveness to pulsatile, but not continuous, infusions of L-dopa. Dluzen D; McDermott J Brain Res Dev Brain Res; 1991 Oct; 62(2):273-6. PubMed ID: 1769106 [TBL] [Abstract][Full Text] [Related]
8. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats. Xu K; Dluzen DE J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416 [TBL] [Abstract][Full Text] [Related]
9. Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-dopa, potassium, and amphetamine. Dluzen DE; McDermott JL; Ramirez VD Exp Neurol; 1991 May; 112(2):153-60. PubMed ID: 2037029 [TBL] [Abstract][Full Text] [Related]
10. The effects of nicotine on dopamine and DOPAC output from rat striatal tissue. Dluzen DE; Anderson LI Eur J Pharmacol; 1998 Jan; 341(1):23-32. PubMed ID: 9489852 [TBL] [Abstract][Full Text] [Related]
11. The effects of L-dopa on in vitro dopamine release from striatum. Snyder GL; Zigmond MJ Brain Res; 1990 Feb; 508(2):181-7. PubMed ID: 2106362 [TBL] [Abstract][Full Text] [Related]
12. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation. Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128 [TBL] [Abstract][Full Text] [Related]
13. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra. Biggs CS; Fisher A; Starr MS Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134 [TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237 [TBL] [Abstract][Full Text] [Related]
15. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats. GoĊembiowska K; Dziubina A Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831 [TBL] [Abstract][Full Text] [Related]
16. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738 [TBL] [Abstract][Full Text] [Related]
17. Effects of 3-O-methyl on L-dopa-facilitated synthesis and efflux of dopamine from rat striatal slices. Chang WY; Webster RA Br J Pharmacol; 1995 Nov; 116(6):2637-40. PubMed ID: 8590982 [TBL] [Abstract][Full Text] [Related]
18. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum. Tyce GM; Rorie DK Life Sci; 1985 Dec; 37(25):2439-48. PubMed ID: 4079658 [TBL] [Abstract][Full Text] [Related]
19. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent. Fisher A; Biggs CS; Eradiri O; Starr MS Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466 [TBL] [Abstract][Full Text] [Related]
20. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry. Hefti F; Melamed E Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]